Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
Sponsor: Eurofeedback
Summary
The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, its favorable cost and versatility in contrast to many singlespectrum lasers, has led to its rapid proliferation and use in a number of different clinical settings. As described in the literature, ANTHÉLIA medical device is intended to treat skin disorders: * Excessive Hairiness (Hirsutism, Hypertrichosis...) * Vascular lesions (Rosacea….) * Pigmented lesions (Lentigo et melasma) * Acne vulgaris
Official title: Post Market Clinical Study of an Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
85
Start Date
2024-01-20
Completion Date
2025-12-01
Last Updated
2024-10-23
Healthy Volunteers
Yes
Interventions
intense pulsed light
intense pulsed light (IPL) using the Medical Device Anthelia
Locations (5)
CH Auxerre
Auxerre, France
HIACT Brest
Brest, France
Centre TrialAzur
Nice, France
CH Périgueux
Périgueux, France
CHU POitiers
Poitiers, France